Browse > Article
http://dx.doi.org/10.4333/KPS.2011.41.6.337

Iontophoretic Transport of Donepezil Hydrochloride through Skin: Flux Enhancement by Chemical Enhancer and Iontophoresis  

Oh, Seaung-Youl (College of Pharmacy, Sookmyung Women's University)
Publication Information
Journal of Pharmaceutical Investigation / v.41, no.6, 2011 , pp. 337-345 More about this Journal
Abstract
The objective of this work is to investigate the effect of chemical enhancer and current on the flux of donepezil hydrochloride (DH) through skin. Ethanol and N-methyl pyrrolidone (NMP) were used as chemical enhancers in combination with iontophoresis. We also have studied the effect of pH on flux and evaluated the role of electroosmosis. In vitro flux study was performed at $33^{\circ}C$, using side-by-side diffusion cell and full thickness hairless mouse skin. Passive flux of DH without enhancer was very small. As the concentration of enhancer increased, passive flux increased. After current application, flux increased markedly and the time to reach maximum decreased. Without enhancer, maximum flux was about 50 fold larger than that obtained without current. These results indicate that electromigration is playing a major role for the transport. As the enhancer concentration increased, flux also increased. NMP and ethanol increased not only the passive delivery, but also the iontophoretic delivery. Flux results indicate that ethanol has better ability than NMP in enhancing the transport of DH. The magnitudes of increase in flux by these enhancers indicate that there is a large synergistic effect in flux enhancement. Flux results from pH study showed that electroosmotic flow is reversed at low pH and the flux is hindered. These results provided some information on the flux enhancing ability of ethanol and NMP in combination with iontophoresis. The data also provided some mechanistic insights into the role of electromigration and electroosmosis on flux through skin.
Keywords
Iontophoresis; Donepezil hydrochloride; N-methyl pyrrolidone; Ethanol; pH;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Heit, M. C., Riviere, J. E., 1997. Electrically-Assisted transdermal drug delivery. Pharmceutical Research. 14(6), 687-761.   DOI
2 Merino, V., Lopez, A., Kalia, Y.N., Guy, R.H., 1999. Electrorepulsion versus electroosmosis : effect of pH on the iontophoresis flux of 5-fluorouracil. Pharm. Res. 16(5), 758-761.   DOI
3 Bommannan, B., Potts, R.O., Guy, R., 1991. Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J. Controlled Release. 16(3), 299-304.   DOI
4 Hirvonen, J., Guy, R.H., 1998. Transdermal iontophoresis: modulation of electroosmosis by polypeptides. J. Controlled Release. 50(1-3), 283-289.   DOI
5 Hirvonen, J., Guy, R.H., 1997. Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances. Pharm. Res. 14, 1258-1263.   DOI
6 Oh, S.Y., 2004. Transdermal delivery of ketoprofen and the effect of electroosmosis. J. Kor. Pharm. Sci. 34(6), 491-497.   과학기술학회마을   DOI
7 Sieg, A., Guy, R.H., Delgado-Charro, M.B., 2004. Noninvasive glucose monitoring by reverse iontophoresis in vivo: application of the internal standard concept. Clin. Chem. 50(8), 1383-1390.   DOI
8 Bath, B.D., White, H.S., Scott, E.R., 2000. Visualization and analysis of electroosmotic flow in hairless mouse skin. Pharm. Res. 17, 471-475.   DOI
9 Marro, D., Guy, R.H., Delgado-Charro, M.B., 2001. Characterization of the iontophoretic permselectivity properties of human and pig skin. J. Contr. Rel. 70, 213-217.   DOI
10 Oda, Y., Ohe, H., Asakawa, N., Yoshida, Y., Sato, T., 1992. Resolution of 1-benzyl-4-[(5, 6-dimethoxy-1-indanon)-2-yl] methylpiperidine hydrochloride enantiomers in plasma by highperformance liquid chromatography with direct injection into avidin-conjugated column. J. Liq. Chromatogr. 15, 2997-3012.   DOI
11 Choi, Y.R., Oh, S. Y., 2010. Electrotransport of Donepezil Hydrochloride from Poly(ethylene oxide) Hydrogel. J. Kor. Pharm. Sci. 40(2), 91-100.   과학기술학회마을   DOI
12 Avdeef, A., 2007. Solubility of sparingly-soluble ionizable drugs. Adv. Drug. Deliv. Rev. 59, 568-590.   DOI
13 Ahad, A., Aqil, M., Kohli, K., Chaudhary, H., Sultana, Y., Mujeeb, M., Talegaonkar, S., 2009. Chemical penetration enhancers: a patent review. Expert Opin. Ther. Pat. 19(7), 969-988.   DOI
14 Koizumi, A., Fujii, M., Kondoh , M., Watanabe, Y., 2004. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur. J. Pharmaceutics. 57(3), 473-478.
15 Barry, B.W., 1987. Mode of action of penetration enhancers in human skin. J. Controlled Rel. 6(1), 85-97.   DOI
16 Williams, A.C., Barry, B.W., 2004. Advanced Drug Delivery Reviews. 56, 603-618.   DOI
17 Pershing, L.K., Lambert, L.D., Knutson, K., 1990. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm. Res. 7, 170-175.   DOI
18 Yum,S.I., 1994. Permeation enhancement with ethanol. In: drug permeation enhancement. Marcel Dekker. New York.
19 Megrab, N.A., Williams, A.C., Barry, B.W., 1995. Oestradiol permeation across human skin, silastic and snake skin membranes: the effects of ethanol/water co-solvent systems. Int. J. Pharm. 116, 101-112.   DOI
20 Crismon, M.L., 1998. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease. Pharmacotherapy. 18(2), 47-54.
21 Kishnani, P.S., Sullivan, J.A., Walter, B.K., Spiridigliozzi, G.A., Doraiswamy, P.M., Krishnan, K.R., 1999. Cholinergic therapy for Down's syndrome. Lancet. 353(9158), 1064-1065.   DOI
22 Rogers, S.L., Friedhoff, L.T., 1996. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. Dementia. 7(6), 293-303.
23 Subedi, R. K., Oh, S. Y., Chun, M. K., Choi, H. K., 2010. Recent advances in transdermal drug delivery. Arch. Pharm. Res. 33(3), 339-351.   DOI
24 Winblad, B., Cummings, J., Andreasen, N., Grossberg , G., Onofrj, M., Sadowsky, C., Zechner, S., Nagel, J., Lane, R., 2007. A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's diseaserivastigmine patch versus capsule. Int. J. Geriatr. Psychiatry. 22(5), 456- 467.   DOI
25 FDA Issues Complete Response Letter for $Aricept^{{\circledR}}$ Patch (donepezil transdermal system), http://www.health.netsimpler.com/ fda-issues-complete-response-letter-for-aricept%C2%AE-patchdonepezil- transdermal-system/, April 25, 2011.
26 Yan, G., Li, S.K., Higuchi, W.I., 2005. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery. J. Control Release. 110(1), 141-150.,   DOI
27 Leboulanger, B., Guy, R. H., Delgado-Charro, M. B., 2004. Reverse iontophoresis for non-invasive transdermal monitoring. Physiol. Meas. 25(3), R35-R50.   DOI
28 Jann, M.W., Shirley, K.L., Small, G.W., 2002. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors. Clin. Pharmacokinet. 41, 719-739.   DOI
29 Lesne, S., Koh, M.T., Kotilinek, L., Kayed, R., Glabe, C.G., Yang, A., Gallagher, M., Ashe, K.H., 2006. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 440, 352-357.   DOI   ScienceOn
30 Zhao, C., Deng, W., Gage, F.H., 2008. Mechanisms and functional implications of adult neurogenesis. Cell. 132(4), 645-660.
31 Lleo, A., Greenberg, S.M., Growdon , J.H., 2006. Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med. 57, 513-533.   DOI
32 Cummings, J., Winblad, B., 2007. A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia. Expert Rev. Neurother. 7(11), 1457-1463.   DOI
33 Olivares, D., Deshpande, V.K., Shi, Y., Lahiri, D.K., Greig, N.H., Rogers, J.T., Huang, X., 2011. N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer's Disease, Vascular Dementia and Parkinson's Disease. Curr. Alzheimer Res. Aug 30.
34 Tariot, P.N., Farlow, M.R., Grossberg, G.T., Graham, S.M., McDonald, S., Gergel, I., 2004. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized placebo controlled trial. Journal of the American Medical Association. 291, 317-324.   DOI
35 Nakano, S., Asada , T., Matsuda, H., Uno, M., Takasaki, M., 2001. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J. Nuclear. Med., 42(10), 1441-1445
36 Tiseo, P. J., Perdomo, C. A., Friedhoff, L. T., 1998. Metabolism and elimination of 14C-donepezil in healthy volunteers: a single- dose study. Br. J. Clin. Pharmacol. 46(S1), 19-24.
37 England, E., 2006. Improving the management of dementia. BMJ. 332, 681-682.   DOI
38 Physician's Desk Reference. 53th ed, 1999. Medical Economics Company, Montvale, NJ, pp. 2364-2367.
39 Jhoo, J.H., Kim, K.W., Huh, Y., Lee, S.B., Park, J.H., Lee, J.J., Choi, E.A., Han, C., Choo, I.H., Youn, J.C., Lee, D.Y., Woo, J.I., 2008. Prevalence of dementia and its subtypes in an elderly urban korean population: results from the Korean Longitudinal Study on Health And Aging (KLoSHA). Dement. Geriatr. Cogn. Disord. 26(3), 270-276.
40 Brookmeyer, R., Johnson, E., Ziegler-Graham, K., Arrighi, H.M., 2007. Forecasting the global burden of Alzheimer's disease. Alzheimers. Dement. 3(3), 186-191.   DOI
41 Querfurth, H.W., LaFerla, F.M., 2010. Alzheimer's disease. N. Engl. J. Med. 362(4), 329-344.   DOI
42 Scarpini, E., Scheltens, P., Feldman, H., 2003. Treatment of Alzheimer's disease: current status and new perspectives. Lancet. Neurol. 2, 539-547.   DOI
43 Francis, P.T., Palmer, A.M., Snape, M., Wilcock, G.K., 1999. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry. 66(2), 137-47.   DOI